References
- [1] S. Nair and S. Rugupathy, “Studies on Cu (II) Mixed Ligand complexes containing a Supha Drug and some Enzyme Constituents”, Journal of Coordination Chemistry, 6 (2); 361-372, 2019.10.1080/00958970903398069
- [2] P.A. Ajibade, and N.H. Zulu, “Metal Complexes of Diisopropylthiourea: Synthesis, Characterization and Antibacterial Studies”, International Journal of Molecular Sciences, Vol. 12, Pp. 7186-7198, 2018.
- [3] J.A. Obaleye, “Marriageology of Chemical Nature: Drug – Metal Complexes Perspective”, The Seventy – fifth Inaugural Lecture University of Ilorin, 2004.
- [4] G. Gutierrez, J. Alzuet, M.I. Borras, F. Gonzalez, A. Sanz, “Castinneiras”, Polyhedron, 20, Pp. 703, 2011.
- [5] G.G. Mohamed, A.M. Mohamed and G. Elkareem, “Synthesis, Characterization and Thermal Studies on Metal Complexes of New Azo compound derived from Sulfa druds”, Spectrochmica Acta Part A, Vol. 68, Pp. 1382 – 1387, 2017.
- [6] World Health Organization. “Malaria Report Estimated P. falciparium infection prevalence among children aged 2-10 years (API, annual parasite index)”, PIPR, P. Falciparium parasite rate, 2015.
- [7] World Health Organization. Malaria Fact sheet, 2017.
- [8] A.S. Kabeer, and A. Azeem, “Syntheis, Characterization and Antibacterial Activity of Imidazole derivatives of 1,10- phenanathroline and their complexes”, International Journal of Advanced Research in Chemical Science, Vol. 1, No. 8, Pp. 40 – 44, 2019.
- [9] B. Kpomah, E.D. Kpomah, and E.A. Enemose, “Activity of some metal complexes of 1,10-phenanthroline and thiosemicarbazone derivatives on Plasmodium bergei infected strains of mice”, Journal of Basic and Applied Chemistry, 36, Pp. 13 – 23, 2018b.
- [10] T. Azar, K. Safoura, R. Arezoo, and Z. Sedigheh, “Synthesis and antiplasmodial activity of novel phenanthroline derivatives: An in vivo study”, Iran J Basic Med Sci., Vol. 21, No. 2, Pp. 202–211, 2018.
- [11] S.H. Kappe, A.M. Vaughan, J.A. Boddey, and A.F. Cowman, “That was then but this is now: malaria research in the time of an eradication agenda”, Science, 328, Pp. 862–866, 2019.10.1126/science.1184785
- [12] K. Beshir, C.J. Sutherland, I. Merinopoulos, N. Durrani, T. Leslie, M. Rowland, and L. Hallett, “Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76”, Antimicrob Agents Chemother, Vol. 54, Pp. 3714–3716, 2017.
- [13] L.L. Smrkovski, R.L. Buck, A.K. Alcantara, C.S. Rodriguez, and C.V. Uylangco, “Studies of resistance to chloroquine, quinine, amodiaquine and mefloquine among Philippine strains of Plasmodium falciparum”, Transa R. Soc. Trop. Med. Hyg., Vol. 79, Pp. 37–41, 2018.10.1016/0035-9203(85)90228-7
- [14] P. Lim, A.P. Alker, N. Khim, N.K. Shah, S. Incardona, S. Doung, P. Yi, D.M. Bouth, C. Bouchier, O.M. Puijalon, S.R. Meshnick, C. Wongsrichanalai, T. Fandeur, J. Le Bras, P. Ringwald, F. Ariey, “Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia”, Malar J., Vol. 8, Pp. 11, 2019.10.1186/1475-2875-8-11
- [15] F.O. Ter Kuile, G. Dolan, F. Nosten, M.D. Edstein, C. Luxemburger, L. Phaipun, T. Chongsuphajaisiddhi, H.K. Webster, and N.J. White, “Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria”, Lancet, Vol. 341, Pp. 1044–1049, 1993.
- [16] L. Cui, and X.Z. Su, “Discovery, mechanisms of action and combination therapy of artemisinin”, Expert Rev Anti Infect Ther., Vol. 7, Pp. 999–1013, 2019.10.1586/eri.09.68
- [17] R. Hadanu, S. Mastjeh, J. Jumina, M. Mustofa, M.A. Widjayanti, and E.N. Sholikhah, “Synthesis and antiplasmodial activity testing of(1)- N -(4-methoxybenzyl)-1,10-phenanthrolinium bromide”, Indones J Chemistry, Vol. 7, Pp. 197–201, 2019.10.22146/ijc.21698
- [18] R. Hadanu, S. Matsjeh, M. Jumina, M.A. Widjayanti, and E.N. Sholikhah, “Synthesis and antiplasmodial activity testing of (1)- N -(4-methoxybenzyl)-1, 10-phenanthrolinium bromide compound”, Proceeding of ICCS, Pp. 24–26, 2017.
- [19] T.J. Egan, K.R. Koch, P.L. Swan, C. Clarkson, D.A. Van Schalkwyk, and P.J. Smith, “In vitro antimalarial activity of a series of cationic 2,2′-bipyridyl- and 1,10-phenanthrolineplatinum (II) benzoylthiourea complexes”, J. Med Chem., Vol. 47, Pp. 2926–2934, 2014.
- [20] M.A. Wijayanti, E.N. Sholikhah, I. Tahir, R. Hadanu, J. Jumina, S. Supargiyono, and M. Mustafa, “Antiplasmodial activity and acute toxicity of N -alkyl and N -benzyl-1, 10-phenanthroline derivatives in mouse malaria model”, J. Health Sci., Vol. 52, Pp. 794–799, 2016.10.1248/jhs.52.794
- [21] E.N. Sholikhah, S. Supargiyono, J. Jumina, M.A. Wijayanti, I. Tahir, R. Hadanu, “Mustofa In vitro antiplasmodial activity and cytotoxicity of newly synthesized N -alkyl and N -benzyl-1, 10-phenanthroline derivatives”, Southeast Asian J Trop Med Public Health, 37, Pp. 1072–1077, 2006.
- [22] D. Fitriastuti, M.I.D. Mardjan, J. Jumina, M. Mustofa, “Synthesis and heme polymerization inhibitory activity (HPIA) assay of antiplasmodium of (1)- N -(3, 4-dimethoxybenzyl)-1, 10-phenanthrolinium bromide from vanillin”, Indones J. Chem., 14, Pp. 1–6, 2018.10.22146/ijc.21260
- [23] H. Shahroosvand, P. Abbasi, B. Notash, L. Najafi, “Separation of functionalized 5, 6-disubstituted-1, 10-phenanthroline for dye-sensitized solar cell applications”, J. Chem., 2019; Article ID 475843.10.1155/2013/475843
- [24] I. Weissbuch, L. Leiserowitz, “Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design”, Chem Rev., 108, Pp. 4899–4914, 2018.
- [25] Y. Shen, B.P. Sullivan, “A Versatile Preparative Route to 5-Substituted-1,10-Phenanthroline Ligands via 1,10-Phenanthroline 5,6-Epoxide”, Inorg Chem., Vol. 34, Pp. 6235–6236, 2018.
- [26] D.E. Golan, A.H. Tashjian, and E.J. Armstrong, “Principles of pharmacology: the pathophysiologic basis of drug therapy”, 4st ed. Lippincott Williams & Wilkins, 2019.
- [27] F. Nosten, M. Van Vugt, R. Price, C. Luxemburger, K.L. Thway, A. Brockman, R. McGready, F. ter Kuile, S. Looareesuwan, and N.J. White, “Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study”, Lancet, 356, Pp. 297–302, 2020.10.1016/S0140-6736(00)02505-8